ACT for Diabetes or, “Achieving Change Together” for Diabetes, is brought to you by Novo Nordisk; a leader in diabetes care, and a health care company focused on changing the way diabetes is viewed and treated in America and around the globe. Novo Nordisk believes that advocacy is essential to achieving policy change and that we need legislation and policies that will help give diabetes the attention it deserves to improve the lives of people affected by diabetes and prediabetes.
The issues that Novo Nordisk supports through ACT for Diabetes are also widely shared and supported by the diabetes patient and professional community. All of these issues are priorities for finding a cure, and improving diabetes prevention, treatment, and control.
One of the most important ways to help achieve these priorities is regular and ongoing communication with our elected officials and other policymakers in Washington, DC. We must continually let them know why we care about the cause of diabetes, inform them about the health and economic burdens of diabetes, and share with them our ideas for how they can best tackle the many challenges posed by diabetes, both today and in the future. Together, we can transform the lives of all people with diabetes if we ACT!